![]() |
COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![]() |
University of Cambridge > Talks.cam > MRC LMB Seminar Series > LMB Seminar - Ribosome Upside Down: Co-translational Protein Biogenesis at the Tunnel Exit
LMB Seminar - Ribosome Upside Down: Co-translational Protein Biogenesis at the Tunnel ExitAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Scientific Meetings Co-ordinator. Our group aims to understand the cellular mechanisms underlying the production of functional proteins. This complex process requires an intricate interplay between the ribosome and a growing number of cellular factors that regulate translation and co-translational protein biogenesis. One of the key topics of our research, which combines structural, biochemical, and biophysical approaches, is the biogenesis of cytosolic and membrane proteins controlled by the nascent polypeptide–associated complex (NAC). I will present recent results that reveal how NAC coordinates the activity of a network of factors and enzymes at translating ribosomes to facilitate virtually all aspects of protein biogenesis, including nascent chain processing, modification, folding, and cellular localization such as targeting to the ER. This talk is part of the MRC LMB Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsOccasional Nuclear Energy Seminars The Danby Society: Downing College Science Society Reading Group on Principles of Neural DesignOther talksConformal unitary circuits and toy quantum gravity The interplay of large-scale tectonics, metamorphism, and earthquake cycles Hh signalling and the anti-tumour immune response: biology and new treatment opportunities LMB Seminar - Higher Order Transient structures and the principle of dynamic connectivity in membrane signaling Greg Cooke on 3D Rocky Exoplanet Atmospheres 100 years of educational trials – no significant difference? |